02 Sep 2021
Following clinical trials showing high effectiveness for inclisiran in treating heart disease, it has now been approved for use by NHS England. The twice yearly injection targets high cholesterol through RNA interference and is expected to prevent early deaths from heart disease and stroke.
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024
Risk of depression during menopause transition not universal
11 Apr 2024
Patients with long Covid continue to show inflammatory proteins in blood
11 Apr 2024
People with obesity and high weight linked to feeling increased pain intensity
11 Apr 2024